Funding · Company
Elucida Oncology, Inc.
Monmouth Junction, NJBiotech & Pharma
Elucida Oncology, Inc. of Monmouth Junction, NJ has disclosed $45M across 2 Form D offerings filed with the SEC between Mar 28, 2022 and Aug 3, 2023.
$45M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$22M
Form D · Aug 3, 2023 ↗
Q3 2023
· 1 amendment, first filed Jun 15, 2023
· revenue No Revenues
$22M
Form D · Mar 28, 2022 ↗
Q1 2022
· revenue No Revenues
Filing details
HeadquartersMonmouth Junction, NJIndustryBiotech & Pharma (Biotechnology)SEC CIK0001704594Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →